Evoke Wealth’s Covetrus, Inc. Common Stock CVET Stock Holding History

Evoke Wealth’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-27	Closed	-$356	–	1402
2019 Q4	$356	Buy	+27	New	+$327	﹤0.01%	1211

Other funds holding CVET

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Evoke Wealth's CVET Position: Q1 2020 in Review

Evoke Wealth sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2020, closing a stake of 27 shares — an estimated $356 sold.

Evoke Wealth first reported a position in CVET in Q4 2019 and held it in 1 quarter. The position peaked at $356 in Q4 2019. 249 funds tracked by Wall St. Rank hold CVET as of Q1 2020.

Evoke Wealth reported no remaining Covetrus, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Evoke Wealth sold 27 Covetrus, Inc. Common Stock shares in Q1 2020, an estimated $356.
Evoke Wealth first reported a position in Covetrus, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
Evoke Wealth's Covetrus, Inc. Common Stock position peaked at $356 in Q4 2019.
249 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2020.

Based on Evoke Wealth's 13F filing for Q1 2020, filed 7 May 2020.